News

Novartis reshuffle puts 120 staff at risk

By 2016-09-05T12:08:00

Novartis signage at the Institute for BioMedical Research building in Cambridge, Massachusetts, US

Source: © Scott Eisen / Bloomberg (via Getty Images)

Commitment to gene and cell therapy treatments emphasised as unit broken up amid pharmaceutical division refocus